Review
Copyright ©The Author(s) 2016.
World J Cardiol. Jan 26, 2016; 8(1): 1-23
Published online Jan 26, 2016. doi: 10.4330/wjc.v8.i1.1
Table 1 Heterogeneities in coronary artery disease/myocardial infarction
Clinical manifestationUnderlying pathologyPathological processes of atherosclerosis
Asymptomatic stenosis Stable or unstable angina pectoris Silent MI Acute MI (NSTEMI and STEMI) Sudden cardiac deathAtheroma positive remodeling Atheroma negative remodeling Plaque rupture/thrombosis Critical stenosis/thrombosis Embolization Spontaneous dissection Anomalous origin/course Coronary spasm Myocardial bridgingEndothelial injury Lipid deposition Oxidative stress/response Inflammation Cellular proliferation/apoptosis Foam cell formation Matrix deposition/degradation Plaque rupture/hematoma/thrombosis Neovascular formation
Table 2 Genes and mutations identified as causal for monogenic familial coronary artery disease
CategoriesGenesChromOMIMMutationsRef.GWAS1
Monogenic CAD genesST6GALNAC51p31.1610134G295A (p.*337Qext*20 stop-loss)[52]No
CYP27A12p35606530G674A (p. Arg225His)[51]No
MEF2A15q26.360832021-bp del in exon 11[34,38]No
LRP612p13.2610947G1079A (p. Arg611Cys) T1298C (p. Asn433Ser)[44,159]No
Gene mutations cause high LDLLDL receptor19p13.2606945> 1000 variants[55]Yes
PCSK91p32.36037769 gain-of-function mutations[63]Yes
ApoB-1002p24.1144010C10580G (p. Arg3527Gln) C10800T (p. Arg3531Cys) rs515135[59,60,84]Yes
LDLRAP1, ARH1p36.11603813ARH1: 432 ins A (p. FS170stop) ARH2: G65A (p. Trp22ter)[66]No
Mutations cause low HDLABCA19q31.1205400Many ABCA1 LoF alleles Rs2230806 > A[78,158]Yes
LCAT16q22.1606967> 80 mutations Rs5923 ↑ CAD in Egyptians[160]Yes
Mutations cause high TGApo C-II19q13.2207750ApoCIISt. Michael p. Gln70Pro[85,86]No
Table 3 Genetic variants associated with a reduced risk of coronary artery disease/myocardial infarction (protective factors against coronary artery disease/myocardial infarction)
ChrGeneProtective allelesRef.
1p13Rs599839 A>GRs646776 T>CC/G haplotype[161,162]
1q22E-selectinG2692A; C901T[163]
1q31GLULRs10911021 T>C, TT allele[164]
1q31IL-10G(-1082)A, GG genotype[165]
1p34LRP 8TCCGC[166]
2p21ABCG 5/8Rs41360247[167]
3p25PPARγ2Pro12Ala homo[168-170]
3p25PPARγC161T[171]
3q27AdiponectinRs1501299 (G276T), TT allele[172-174]
8q21FABP4Rs77878271[175]
6p12.3PLA2G7R92H[176]
6p25.3FXIIIVal34Liu[177,178]
7q21.3PON1/2Gln192Arg[112,116]
7q32.3KLF14Rs4731702 T/T allele[179]
7q36INSIG1Hap3 (T/G/A)[180]
9q31.1ABCG1G1051A, r219K, KK allele[78]
11q23.3APOC3R19X[181]
13q34FVIIR353Q; QQ allele A2 allele (without a 10 bp insertion)[182]
16q13FKNT280M allele; Rs4329913; Rs7202364[183,184]
16q24NADPH p22phoxC242T[185,186]
17p13.2GP1bαThr/Th; TT haplotype[187]
21q22.1MRPS6C699T (TT) or T1080C (CC)[64]
Table 4 Genetic variants associated with the risk of in-stent restenosis
Chr locationsGene symbolsGenetic polymorphismsEffects on risk of ISRPathway involvedRef.
1p36.3MTHFRC677T↑ ISRMetabolism[188]
1q32.1IL10G(-2849)A; G(-1082)A; A4259G↑ ISRInflammation[189]
1p35.1CX37C1019T↑ ISR in menInflammation[190,191]
2q14IL 1BC(-511)T↑ ISRInflammation[192]
2q14.2IL-1RNT8006C↓ ISRInflammation[154]
3p21.3GPx-1C599T (rs1050450)↑ ISRThrombosis[193]
rs8179164 A>T↑ ISR[194]
3p24KAT2Brs6776870 G>C; rs2929404 T>C; rs17796904 T>C; rs4858767 G>C↑ ISREpigenetic/gene expression[194]
3q24AGTR1rs5182 T>C↑ ISRVascular homeostasis[194]
3q24P2RY12P2Y12 Haplotype H1 (5 P2Y12 ht-SNPs)↑ ISRThrombosis[195]
3q27AdiponectinT(+45)G rs2242766↑ ISRInflammation[196]
4q13IL-8A(-251)T + C(781)T↑ ISRSInflammation[197]
4q28FGBrs1044291 T>C↑ ISRThrombosis[194]
5q12CCNB1rs350099 C>T (TT); rs350104 T>C (CC); rs164390 T>G (GG); TT/CC/GG haplotype↑ ISRCell cycling[198]
↑↑ ISR
5q31.1CD14C(-260)T↑ ISRInflammation[199]
5q34miRNA-146ars2910164>G (G/C)↑ ISRInflammation[200]
rs2910164>G (C/C)↓ ISR
6p21.3TNFαT (-857)C +C(-1031)T↑ ISRInflammation[201]
6p21.3RAGET(-374)A↓ ISRInflammation[202]
6q25.1αERPvuII (C/T) > (TT)↑ ISR in womenCell cycling[203]
7q22.1PAI-15G/5G↑ ISR (smoker)Thrombosis[204]
↓ ISR (nonsmoker)
7q36.1eNOS298C/T (p. Glu298Asp)(rs1799983>T); T(-786)C↑ ISRCell proliferation[193,205,206]
11q22.3MMP12rs12808148 C>T; rs17099726 G>T↑ ISRMatrix deposition[194]
11q22.2IL-18G(-137)T↑ ISRInflammation[207]
11q13.4UPC3C(-55C)T↑ ISRMetabolism[208]
12p13.1p27kip1(-838)AA↓ ISRCell cycling[209]
12q13.11VDRBlock 2 AA haplotype↑ ISRMetabolism[210]
rs11574027 T>G; rs11574077 G>A↑ ISR[194]
13q12ALOX5APrs10507391 T>A; rs17216473 G>A↑ ISRLipid metabolism[211]
rs17222814G>A↓ ISR
17p13.1p53Arg72Pro↑ ISRCell cycling[212]
17q23.3ACED allele: no 287-bp Alu repeats insertion in intron 16↑ ISRCell cycling[29-32,213-215]
19p13.2ICAM-1K469E↑ ISRCell-cell interaction[216]
21q22.3CD18C1323T↓ ISRInflammation[217]
22q13.1HO-1> 29 TG repeats in promoter↑ ISROxidative stress[218]